Skip to main content
. 2022 Jun 9;13:862709. doi: 10.3389/fphar.2022.862709

FIGURE 3.

FIGURE 3

Nar inhibited high-glucose-induced VSMC proliferation. (A) CCK-8 assay showed that Nar reduced the viability of high-glucose-induced VSMCs at 24 and 48 h, p < 0.05. (B,C) Flow cytometry showed a lower cell proliferation rate in the Nar group than in the HG group. (D) Immunofluorescent staining of PCNA (magnification: 200×). (E,F) Western blot analysis showed PCNA expression associated with different treatments of VSMCs, * p < 0.05 compared with Control group, ## p < 0.01 compared with HG group.